296856.fig.002a
(a)
296856.fig.002b
(b)
Figure 2: Frequency of clinical scores of asthma in patients from Group 1 at day zero (D0) and one to seven days (D1–D7) after treatment with placebo (Plac) of Albendazole (Alb) and placebo of Praziquantel (PZQ) (a); and at day zero (D0) and one to seven days (D1–D7) after treatment with Albendazole or Praziquantel (Group 2) (b). Praziquantel was given seven days after the treatment with Albendazole in the Group 2. Data were represented as m e a n ± S D . There was no significant difference in the frequency of asthma scores between D0 versus D1–D7 in none of groups ( 𝑃 > 0 . 0 5 ; Chi-square Test for Independence).